18:00-19:00 Welcome Reception Exhibition Area

Transcription

1 Thursday, February 28 th, :00-18:00 Registration 18:00-19:00 Welcome Reception Exhibition Area Friday, March 1 st, :00-11:10 Plenary Session 1: Opening Session Hall A Chairs: Stevo Julius, USA, Rimvydas Slapikas, Lithuania, Reuven Zimlichman, Israel 09:00 Greetings 09:10 Hemodynamic and Sympathetic Tone Changes in the Course of Prehypertension, Stevo Julius, USA 09:40 ARBs vs ACE inhibitors: is the Better the Enemy of the Good? Thomas Unger, the Netherlands 10:10 The Heart and the Kidney: a Forty Years Retrospective, Efrain Reisin, USA 10:40 Prehypertension and Hypertension Definition, Diagnosis and Treatment Options, Reuven Zimlichman, Israel 11:10-11:40 Coffee Break, Exhibition Visit and Posters Viewing 11:40-13:40 Plenary Session 2: Diagnostic Challenges of Organ Target Damage in Patients with Hall A Prehypertension Chairs: Sekib Sokolovic, Bosnia and Herzogovina. 11:40 Microvascular Structrural Alterations: what is New? Damiano Rizzoni, Italy 12:10 Significance of Higher Systolic Blood Pressure in Young People, Michael Bursztyn, Israel 12:40 Prehypertension and Associated Cardiovascular Risk Profiles in Different Populations, Andrzej Januszewicz, Poland 13:10 Why the Sprint Study should not Influence our Treatment of Patients with Hypertension - and why Target Systolic Blood Pressure is 130 and not 120 mmhg, Sverre E. Kjeldsen, Norway 13:40-14:30 Lunch Break, Exhibition Visit and Posters Viewing 14:30-15:15 Satellite Symposium Hall A The session supported by Servier Simple Solutions to Ensure Efficacy in Hypertensive Patients with High Cardiovascular Risk Gintare Sakalyte, Lithuania 1

2 15:15-16:55 Plenary Session 3: A Contemporary Approach to Arterial Hypertension Management Hall A Chairs: Dalius Jatuzis, Lithuania, Bojan Jelakovic, Croatia, 15:15 Combination Therapy in Hypertension, Stefano Taddei, Italy 15:35 Treatment of Hypertension induced Albuminuria, Bojan Jelakovic, Croatia 15:55 Blood Pressure Variability, Methodological Aspects and Clinical Implications, Gianfranco Parati, Italy 16:15 Stress as a Trigger of Autoimmune Disease, Ljudmila Stojanovich, Serbia 16:35 Renal Denervation in Search for New Indications, Alexander Prejbisz, Poland 16:55-17:15 Coffee Break, Exhibition Visit and Posters Viewing 17:15-18:35 Plenary Session 4: Hot Topics in Arterial Hypertension (joint Session with Lithuanian Hall A Society of Hypertension, Latvian Society of Hypertension and Atherosclerosis and Lithuanian Society of Cardiology) Chairs: Marius Miglinas, Lithuania, Karlis Trusinskis, Latvia, Gintare Sakalyte, Lithuania( 17:15 Microvascular Dysfunction and Prediabetes: a Vicious Cycle, Coen D.A. Stehouwer, The Netherlands 17:35 New Insights into Vascular Disease: from Ageing to Calcification, Catherine Shanahan, UK 17:55 There is an Elephant in the Room: Hurdles to Achieve Blood Pressure Contol in Daily Practice, Marius Miglinas, Lithuania 18:15 Masked Uncontrolled Hypertension in Normotensive Patients, Kārlis Trušinskis, LATVIA 2

3 Saturday, March 2 nd, :30-10:30 Plenary Session 5: New horizons in dyslipidaemia management Hall A Chairs: Rimvydas Slapikas, Lithuania, Gustavs Latkovskis, Latvia 08:30 LDL-C Lowering as a Pathway to Reduce Cardiovascular Events how Low should we Go? Rimvydas Slapikas, Lithuania 09:00 New era in Lipid Management, Margus Viigimaa, Estonia 09:30 Familial Hypercholesterolemia: Underdiagnosed and Undertreated yet Common and High Risk Disease, Gustavs Latkovskis, Latvia 10:00 Discussions 10:30-11:00 Coffee Break, Exhibition Visit and Posters Viewing 11:00-13:00 Plenary Session 6: Prediabetes and Diabetes - Mechanisms of Cardiovascular Damage Hall A Chairs: Branislav Milovanovic, Serbia, Rasa Verkauskiene, Lithuania 11:00 Big Aorta in Diabetic Patient with Hypertension: what to do and what does the Guidelimnes Say? Martin Czerny, Germany 11:20 Renal Fibromuscular Dysplasia: is it really a (Pre) Hypertensive Disorder? Peter W. de Leeuw, the Netherlands 11:40 Chronic Fatigue Syndrome-New Approach in Understanding of Etiology of Cardiovascular and Metabolic Disorders, Branislav Milovanovic, Serbia 12:00 Arterial Stiffness in the Prehypertensive State, Sekib Sokolovic, Bosnia and Herzegovina 12:20 Novel Anti-Diabetic Drugs and Cardiovascular Risk Reduction, Zydrune Visockiene, Lithuania 12:40 Stroke Prevention in Atrial Fibrillation -do we know the Answers to all the Questions? Nora Kupstyte-Kristapone, Lithuania 13:00-14:00 Lunch Break, Exhibition Visit and Posters Viewing 11:00-13:00 Parallel Session 3: Free Papers Hall B Chairs: TBA 13:00-14:00 Lunch Break, Exhibition Visit and Posters Viewing 3

4 14:00-15:40 Plenary Session 7: Hypertension Related Target Organ Damage: the Heart Hall A Chairs: Jelena Celutkiene, Lithuania, Thomas Weber, Austria 14:00 Central Haemodynamics and Cardiovascular Risk Prediction: an Individual Participant Metaanalysis, Ian Wilkinson, UK 14:20 COPD and HF - Beta-Blockade and Beta-Stumulation Hf in Lithuania: Epidemiology, Observational Data and Management, Jelena Celutkiene, Lithuania 14:40 NOACS and Reversal Agents, Cetin Erol, Turkey 15:00 Pulsatile Hemodynamics in Heart Failure, Thomas Weber, Austria 15:20 New Guideline for Statin Treatment in Primary Prevention: The Contribution of Coronary Atherosclerosis Imaging, Joe Shemesh, Israel 15:40-16:00 Coffee Break, Exhibition Visit and Posters Viewing 16:00-17:00 Plenary Session 8: Joint session with ESC Hall A Chairs: TBA 16:00 TBA 16:20 TBA 16:40 TBA 17:00-18:00 Plenary Session 9: The Epidemic of Obesity- New Concepts and Therapeutic Approach Hall A Chairs: Arno Schmidt Trucksass, Switzerland, TBA 17:00 Fit or Lean Importance for Metabolic Syndrome, Arno Schmidt Trucksass, Switzerland 17:20 Food Products that Increase Blood Pressure, Marcin Adamczak, Poland 17:40 Subclinical Cardiovascular Target Organ Damage in Newly Diagnosed Arterial Hypertension, Savatore Novo, Italy 18:00 Metabolically Healthy Obesity- does it Exist? If so, how? Peter Nilsson, Sweden 20:00-22:30 Gala Dinner (Optional) 4

5 Sunday, March 3 rd, :30-10:30 Plenary Session 10: Arterial Hypertension, Metabolic Disease and Cardiovascular Risk Hall A Prediction Chairs: Carmel McEniery, UK, Zaneta Petrulioniene, Lithuania 08:30 Body Composition and Cardiovascular Haemodynamics in Young Adults, Carmel McEniery, UK 08:50 Home and Office Blood Pressure Measurements as Determinants of Hypertension Mediated Organ Damage: The Finn-Home Study, Ilkka Kantola, Finland 09:10 The Cardiometabolic Patient: how to Evaluate Risk? Aleksandras Laucevicius, Lithuania 09:30 The Different Faces Of Cardiovascular Risk: The Spectrum of Risk is Wider than Currently Accepted and Therefore Prevention and Treatment should be Tailored for any Individual Patient, Dov Gavish, Israel 09:50 From Moderate to Very High Cardiovascular Risk: Patient s Journey, Primary Health Care Provider Possibilities, Gediminas Urbonas, Lithuania 10:10 Discussion 10:30-11:00 Coffee Break, Exhibition Visit and Posters Viewing 11:00-13:00 Plenary Session 11: Hypertensive Disorders of Pregnancy H Chair: Danuta Czarnecka, Poland 11:00 Hypertension in Pregnancy- A Future Risk Factor for Cardiometabolic and Renal Complications, Bryan Rayner, South Africa 11:20 Pre-Eclampsia and Peripartum Cardiomyopathy do they share Common Patomechanisms, Agnieszka Olszanecka, Poland 11:40 In whom Suspect and how to Diagnose Secondary Hypertension in Pregnancy? Aleksander Prejbisz, Poland 12:00 Prenatal Programming of Future Blood Pressure and Caodiovascular Disease: Children Of Mothers with Hypertensive Disorders of Pregnancy and Children with Low Birth Weight, Mieczysław Litwin, Poland 12:20 Management of Pregnancy Hypertension what should be Target Blood Pressure on Office, Home and Ambulatory Measurement? Katarzyna Stolarz-Skrzypek, Poland 12:40 Closing Remark Stevo Julius, USA, Rimvydas Slapikas, Lithuania, Reuven Zimlichman, Israel 5